v3.26.1
Shareholders’ equity (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table summarizes the Company’s stock option activity under the Pre-IPO Plan since December 31, 2025:
Number of
Shares		Weighted-
Average Exercise
Price 
Outstanding as of December 31, 202524,089,219$1.07 
Granted–– 
Exercised(2,862,389)0.27 
Forfeited–– 
Outstanding as of June 30, 202621,226,830$1.18 
Options exercisable as of June 30, 202621,226,830$1.18 
The following table summarizes the Company’s stock option activity under the 2020 Plan since December 31, 2025:
Number of
Shares		Weighted-
Average Exercise
Price
Outstanding as of December 31, 202536,376,041$7.38 
Granted10,545,9513.50 
Exercised(443,561)3.49 
Forfeited(1,372,144)6.98 
Outstanding as of June 30, 202645,106,287$6.53 
Options exercisable as of June 30, 202621,588,549$9.40 
Schedule of Restricted Share Units Activity
The following table summarizes the Company’s RSU activity under the 2020 Plan since December 31, 2025:
Number of
Shares		Weighted-
Average Grant
Date Fair Value
Outstanding as of December 31, 20258,837,384$4.75 
Granted4,126,5743.45 
Vested and settled(2,562,972)5.56 
Forfeited(559,646)4.36 
Outstanding as of June 30, 20269,841,340$4.02 
Schedule of Stock-Based Compensation Expense
Stock-based compensation was classified in the condensed consolidated statements of loss and comprehensive loss as follows:
Three months ended June 30,Six months ended June 30,
2025202620252026
Research and development expenses$7,506 $6,714 $15,642 $13,753 
Sales, general, and administrative expenses6,702 5,572 13,351 10,546 
$14,208 $12,286 $28,993 $24,299